Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Boehringer Cuts 724 US Jobs To 'Reinvent' Pharma Business

Executive Summary

Boehringer Ingelheim is cutting 724 jobs in the US to "help us reinvent the way we serve the needs of our patients, and enable us to continue to make significant investments in research and development," which aligns with comments earlier this year by the German company's outgoing CEO.


Related Content

2Q Pharma Results Preview: What Lies Ahead
Green Shoots: Pharma Investments In Early Innovation Support Biotech Growth
Barner Goes Out On A High As Boehringer Ingelheim Returns To Growth


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts